Shanghai, China, April 23, 2013 --(PR.com
)-- Shanghai Yaxin Biotechnology Co., Ltd. offers two new recombinant proteins. Recombinant Bovine enterokinase, also known as enteropeptidase, is a specific protease used for tag removal, while V8 Protease (Endoproteinase GluC) is highly important for protein structure and sequence analysis.
"Insisting on scientific and technological innovation has been our priority and we will pursue in that direction by developing new products that are adapted to the rapidly changing biotech market," said Zhao Zhi, the founder of YaxinBio.
Shanghai Yaxin Biotechnology Co., Ltd. is a biotech company founded in 2008 that focuses on the research and the production of recombinant proteins. YaxinBio is specialized in the research and the production of Animal Origin Free recombinant carboxypeptidase B and recombinant trypsin, which are of high importance for the production of human recombinant insulin. Shanghai YaxinBio, located in Shanghai Juke Biotech Park, is ISO 9001 registered company since 2009.
For more information, please contact :